tradingkey.logo
tradingkey.logo
Pesquisar

Quest Diagnostics Inc

DGX
Adicionar à lista de desejos
188.329USD
-1.851-0.97%
Horário de mercado ETCotações atrasadas em 15 min
20.90BValor de mercado
20.45P/L TTM

Quest Diagnostics Inc

188.329
-1.851-0.97%

Mais detalhes de Quest Diagnostics Inc Empresa

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.

Informações de Quest Diagnostics Inc

Código da empresaDGX
Nome da EmpresaQuest Diagnostics Inc
Data de listagemDec 17, 1996
CEODavis (James E)
Número de funcionários45000
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 17
Endereço500 Plaza Drive
CidadeSECAUCUS
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal07094
Telefone19735202700
Sitehttps://www.questdiagnostics.com/
Código da empresaDGX
Data de listagemDec 17, 1996
CEODavis (James E)

Executivos da empresa Quest Diagnostics Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Catherine T. (Cathy) Doherty
Ms. Catherine T. (Cathy) Doherty
Executive Vice President - Regional Businesses
Executive Vice President - Regional Businesses
71.62K
-1.68%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Lead Independent Director
Lead Independent Director
46.45K
+1.80%
Mr. Michael E. Prevoznik
Mr. Michael E. Prevoznik
Senior Vice President, General Counsel
Senior Vice President, General Counsel
43.30K
+9.07%
Mr. Gary M. Pfeiffer
Mr. Gary M. Pfeiffer
Independent Director
Independent Director
29.57K
-12.98%
Mr. Timothy L. (Tim) Main
Mr. Timothy L. (Tim) Main
Independent Director
Independent Director
26.30K
--
Ms. Vicky B. Gregg
Ms. Vicky B. Gregg
Independent Director
Independent Director
17.17K
+0.40%
Mr. Karthik Kuppusamy
Mr. Karthik Kuppusamy
Senior Vice President - Clinical Solutions
Senior Vice President - Clinical Solutions
15.50K
+0.25%
Ms. Denise M. Morrison
Ms. Denise M. Morrison
Independent Director
Independent Director
11.92K
+0.56%
Ms. Tracey C. Doi
Ms. Tracey C. Doi
Independent Director
Independent Director
6.58K
+1.72%
Mr. Robert B. (Rob) Carter
Mr. Robert B. (Rob) Carter
Independent Director
Independent Director
2.71K
+0.26%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Catherine T. (Cathy) Doherty
Ms. Catherine T. (Cathy) Doherty
Executive Vice President - Regional Businesses
Executive Vice President - Regional Businesses
71.62K
-1.68%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Lead Independent Director
Lead Independent Director
46.45K
+1.80%
Mr. Michael E. Prevoznik
Mr. Michael E. Prevoznik
Senior Vice President, General Counsel
Senior Vice President, General Counsel
43.30K
+9.07%
Mr. Gary M. Pfeiffer
Mr. Gary M. Pfeiffer
Independent Director
Independent Director
29.57K
-12.98%
Mr. Timothy L. (Tim) Main
Mr. Timothy L. (Tim) Main
Independent Director
Independent Director
26.30K
--
Ms. Vicky B. Gregg
Ms. Vicky B. Gregg
Independent Director
Independent Director
17.17K
+0.40%

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de abr
Moeda: USDAtualizado em: seg, 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
Routine clinical testing services
5.96B
54.00%
Gene-based and esoteric testing services
4.19B
38.00%
Anatomic pathology testing services
662.10M
6.00%
All other
220.70M
2.00%
COVID-19 testing services
0.00
0.00%
Por RegiãoUSD
Nome
Receita
Proporção
United States
11.04B
100.00%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Routine clinical testing services
5.96B
54.00%
Gene-based and esoteric testing services
4.19B
38.00%
Anatomic pathology testing services
662.10M
6.00%
All other
220.70M
2.00%
COVID-19 testing services
0.00
0.00%

Distribuição de ações

Atualizado em: dom, 10 de mai
Atualizado em: dom, 10 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Vanguard Capital Management, LLC
6.46%
BlackRock Institutional Trust Company, N.A.
5.58%
T. Rowe Price Associates, Inc.
5.54%
Vanguard Portfolio Management, LLC
5.49%
State Street Investment Management (US)
4.86%
Outro
72.07%
Investidores
Investidores
Proporção
Vanguard Capital Management, LLC
6.46%
BlackRock Institutional Trust Company, N.A.
5.58%
T. Rowe Price Associates, Inc.
5.54%
Vanguard Portfolio Management, LLC
5.49%
State Street Investment Management (US)
4.86%
Outro
72.07%
Tipos de investidores
Investidores
Proporção
Investment Advisor
56.33%
Investment Advisor/Hedge Fund
29.63%
Research Firm
5.13%
Pension Fund
2.82%
Hedge Fund
2.76%
Bank and Trust
1.77%
Sovereign Wealth Fund
1.24%
Individual Investor
0.48%
Family Office
0.06%

Participação acionária institucional

Atualizado em: dom, 5 de abr
Atualizado em: dom, 5 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q1
1896
110.61M
99.92%
-3.16M
2025Q4
1760
110.09M
99.89%
--
2025Q3
1807
110.10M
100.22%
-700.93K
2025Q2
1819
110.85M
98.75%
+3.78M
2025Q1
1805
107.66M
97.04%
-1.03M
2024Q4
1782
103.84M
96.80%
+1.47M
2024Q3
1731
102.61M
95.91%
+134.75K
2024Q2
1739
102.41M
97.25%
-2.03M
2024Q1
1743
104.12M
95.50%
-1.89M
2023Q4
1768
101.63M
97.47%
-890.08K
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
6.17M
5.62%
+44.49K
+0.73%
Dec 31, 2025
T. Rowe Price Associates, Inc.
6.13M
5.58%
-707.60K
-10.35%
Dec 31, 2025
State Street Investment Management (US)
5.38M
4.9%
+158.62K
+3.04%
Dec 31, 2025
Boston Partners
3.91M
3.56%
-123.56K
-3.06%
Dec 31, 2025
JP Morgan Asset Management
3.74M
3.4%
-38.83K
-1.03%
Dec 31, 2025
Geode Capital Management, L.L.C.
3.03M
2.76%
-8.28K
-0.27%
Dec 31, 2025
Victory Capital Management Inc.
2.13M
1.94%
-217.55K
-9.28%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
1.93M
1.76%
+24.04K
+1.26%
Dec 31, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
iShares U.S. Healthcare Providers ETF
3.1%
Madison Dividend Value ETF
2.17%
State Street SPDR S&P Health Care Services ETF
1.99%
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
1.81%
First Trust Total US Market AlphaDEX ETF
1.8%
Invesco S&P 500 Equal Weight Health Care ETF
1.59%
Acruence Active Hedge US Equity ETF
1.26%
First Trust Health Care Alphadex Fund
1.21%
Timothy Plan High Dividend Stock ETF
1.19%
VictoryShares US Value Momentum ETF
1.01%
Ver Mais
iShares U.S. Healthcare Providers ETF
Proporção3.1%
Madison Dividend Value ETF
Proporção2.17%
State Street SPDR S&P Health Care Services ETF
Proporção1.99%
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
Proporção1.81%
First Trust Total US Market AlphaDEX ETF
Proporção1.8%
Invesco S&P 500 Equal Weight Health Care ETF
Proporção1.59%
Acruence Active Hedge US Equity ETF
Proporção1.26%
First Trust Health Care Alphadex Fund
Proporção1.21%
Timothy Plan High Dividend Stock ETF
Proporção1.19%
VictoryShares US Value Momentum ETF
Proporção1.01%

Dividendo

Um total de 1.26B USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Feb 10, 2026
DGX.NB Interim Cash Dividend of gross USD 0.86 paid on Apr 20, 2026 going ex on Apr 06, 2026
Apr 06, 2026
Apr 20, 2026
Apr 06, 2026
Nov 11, 2025
DGX.NB Interim Cash Dividend of gross USD 0.8 paid on Jan 28, 2026 going ex on Jan 13, 2026
Jan 13, 2026
Jan 28, 2026
Jan 13, 2026
Aug 13, 2025
DGX.NB Final Cash Dividend of gross USD 0.8 paid on Oct 20, 2025 going ex on Oct 03, 2025
Oct 03, 2025
Oct 20, 2025
Oct 03, 2025
May 14, 2025
DGX.NB Interim Cash Dividend of gross USD 0.8 paid on Jul 21, 2025 going ex on Jul 07, 2025
Jul 07, 2025
Jul 21, 2025
Jul 07, 2025
Jan 30, 2025
DGX.NB Interim Cash Dividend of gross USD 0.8 paid on Apr 21, 2025 going ex on Apr 07, 2025
Apr 07, 2025
Apr 21, 2025
Apr 07, 2025
Nov 12, 2024
DGX.NB Interim Cash Dividend of gross USD 0.75 paid on Jan 29, 2025 going ex on Jan 14, 2025
Jan 14, 2025
Jan 29, 2025
Jan 14, 2025
Aug 14, 2024
DGX.NB Final Cash Dividend of gross USD 0.75 paid on Oct 21, 2024 going ex on Oct 04, 2024
Oct 04, 2024
Oct 21, 2024
Oct 04, 2024
May 15, 2024
DGX.NB Interim Cash Dividend of gross USD 0.75 paid on Jul 22, 2024 going ex on Jul 08, 2024
Jul 08, 2024
Jul 22, 2024
Jul 08, 2024
Feb 01, 2024
DGX.NB Interim Cash Dividend of gross USD 0.75 paid on Apr 22, 2024 going ex on Apr 05, 2024
Apr 08, 2024
Apr 22, 2024
Apr 05, 2024
Nov 14, 2023
DGX.NB Interim Cash Dividend of gross USD 0.71 paid on Jan 31, 2024 going ex on Jan 16, 2024
Jan 17, 2024
Jan 31, 2024
Jan 16, 2024
Ver Mais

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
KeyAI